Business Segment (Tables)

12 Months Ended

Dec. 31, 2023

Business Segment [Abstract]

Schedule of Business Segment

Summarized below is information about the Company’s operations for the years ended December 31, 2023 and 2022 by business segment:

	Revenues				Losses
	2023		2022		2023			2022
FOXO Labs (a)	$	126	$	483	$	(2,149	)	$	(2,769	)
FOXO Life		19		28		(1,645	)		(3,735	)
		145		511		(3,794	)		(6,504	)
Corporate and other (b)		-		-		(21,593	)		(87,311	)
Interest expense		-		-		(1,064	)		(1,440	)
Total	$	145	$	511	$	(26,451	)	$	(95,255	)

(a) For 2023, FOXO Labs losses include $1,313 for the write off of supplies.

(b) For 2023, Corporate and other includes stock-based compensation, including amortization of consulting fees paid in stock, of $2,586, depreciation and amortization expense of $1,279, impairment charges of $2,633, change in fair value of warrant liability of $303, loss from PIK Note Amendment and 2022 Debenture Release of $3,521 and $19 of other income, net. For 2022, Corporate and other includes stock-based compensation, including the consulting agreement, Cantor Commitment Fee and vendor shares expense of $17,708, depreciation and amortization expense of $1,487, change in fair value of convertible debentures and warrant liability expense of $26,104, $1,307 for impairment charge and $27,544 of other non-operating expenses. See Notes 5, 6, 7, 9 and 11 for additional information.